Thyroid Cancer (Undifferentiated/Anaplastic Carcinoma)

Thyroid Cancer (Undifferentiated/Anaplastic Carcinoma) is a rare but very aggressive type of cancer that affects the thyroid gland, an important organ in the neck that controls metabolism. This cancer grows rapidly and can spread quickly to nearby tissues and other parts of the body. It often causes a rapidly enlarging neck mass, difficulty swallowing, and breathing problems due to compression of the windpipe. Because it is so aggressive, it can severely impact overall health and requires urgent medical attention. Unlike other thyroid cancers, it does not respond well to typical treatments and has a poor prognosis.

Thyroid Cancer (Undifferentiated/Anaplastic Carcinoma) is a highly malignant neoplasm arising from follicular thyroid cells that have lost differentiation, resulting in a loss of normal thyroid function. It is characterized by rapid growth, local invasion, and early distant metastasis. The pathogenesis often involves mutations in tumor suppressor genes such as TP53 and alterations in the PI3K/AKT and MAPK signaling pathways. Histologically, it shows pleomorphic giant cells, spindle cells, and areas of necrosis. Clinically, it presents with a rapidly enlarging neck mass, compressive symptoms, and often vocal cord paralysis. This carcinoma is notable for its resistance to radioactive iodine and poor response to conventional chemotherapy, making it one of the most lethal thyroid malignancies.